{
  "id": "620580afc9dfcb9c0900002f",
  "type": "yesno",
  "question": "Does daily atemoya juice intake change the pharmacokinetics of CYP1A2 substrates?",
  "ideal_answer": "No, atemoya juice does not change the pharmacokinetics of CYP1A2 substrates.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/34881402"
  ],
  "snippets": [
    {
      "text": "Atemoya juice significantly inhibited CYP1A2 activity in human liver microsomes, but not the activities of CYP2C9 and CYP3A. In spite of this inhibition, preadministration of atemoya had no effect on the pharmacokinetics of phenacetin, a CYP1A2 substrate, in rats. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/34881402",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The results indicate that a daily intake of atemoya would not change the pharmacokinetics of CYP1A2 substrates such as phenacetin as well as CYP2C9- and CYP3A-substrate drugs.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/34881402",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "Yes"
}